Trial intelligence / Profile preview

Mifepristone versus enantone for uterine fibroids

ChiCTR-IIR-15007521Phase 3Completed

Sponsor
Peking University First Hospital
Start
May 2004
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 3, randomised trial of mifepristone and leuprolide in Fibromyoma (LM) (3 arms), sponsored by Peking University First Hospital. Primary endpoint: Change in volume of the largest uterine fibroid. Started May 2004; status: completed.

02

Drugs

mifepristoneleuprolide
03

Conditions

Fibromyoma (LM)

Beyond the preview

Go deeper on ChiCTR-IIR-15007521.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IIR-15007521.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call